Yanjuan Xiong - Cancer Institute and Hospital, Tianjin Medical University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A Prospective Study of Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: the Keystone-001 Trial

Xiaobin Shang,Yongjie Xie,Jinpu Yu,Chen Zhang, Gang Zhao,Fei Liang,Liang Liu,Weihong Zhang,Runmei Li,Wenwen Yu,Jie Yue,Chuangui Chen,Xiaofeng Duan,Zhao Ma, Zuoyu Chen,Yanjuan Xiong,Fan Yang,Jianyu Xiao,Rui Zhang, Pengpeng Liu,Yanan Cheng,Fuliang Cao, Feng Guo,Guoyan Liu,Bin Meng,Dejun Zhou,Yan Sun,Xiubao Ren,Jun Yu,Jihui Hao, Hongjing Jiang

Cancer cellno. 10 (2024): 1747-1763.e7

引用0浏览0WOS引用

First-line Treatment with Gefitinib in Combination with Bevacizumab and Chemotherapy in Advanced Non-Squamous NSCLC with EGFR-mutation

Yanjuan Xiong, Lu Wang, Weihong Zhang, Yuan Meng, Yang Wang, Meng Shen, Li Zhou, Runmei Li, Yingge Lv, Shengguang Wang,Xiubao Ren,Liang Liu

BMC CANCERno. 1 (2024)

引用0浏览0WOS引用

Therapeutic Effect of Haploidentical Peripheral Blood Stem Cell Treatment on Relapsed/refractory Ovarian Cancer

Runmei Li, Dong Zhang,Baozhu Ren,Shui Cao, Li Zhou,Yanjuan Xiong,Qian Sun,Xiubao Ren

Bulletin du cancerno. 3 (2023): 285-292

引用1浏览0WOS引用

Neoadjuvant Pembrolizumab Combined with Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase 2 Trial (Keystone-001)

Xianwen Shang, Yi Xie, Jinpu Yu,Chen Zhang, Gang Zhao,Fei Liang,Liang Liu,Wei Hong Zhang,Runmei Li,Wenwen Yu,Jie Yue,Chuangui Chen,Xiaofeng Duan,Zhao Ma,Zuoyu Chen,Yanjuan Xiong,Fan Yang,Jianyu Xiao, Rui Zhang,Pengpeng Liu,Yanan Cheng,Fuliang Cao,Feng Gao,Guoyan Liu,Bin Meng,Dejun Zhou,Yan Sun,Xiubao Ren,Yu J,Hongjing Jiang

openalex（2023）

引用0浏览0引用

Long-term Outcome for Patients with Advanced Non‒small-Cell Lung Cancer Treated by Autologous Cytokine-Induced Killer (CIK) Cell Immunotherapy in Combination with Sintilimab Plus Chemotherapy: NSCLC-CCICC-002

Liang Liu,Li Zhou,Xiubao Ren,Weihong Zhang,Yanjuan Xiong

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events

Weijiao Du,Li Zhou, Lin Yang,Runmei Li, Liang Liu,Xinwei Zhang, Yang Wang,Meng Shen,Xiubao Ren,Yanjuan Xiong,Weihong Zhang, Yuan Meng,Ying Han

CANCER BIOLOGY & MEDICINE（2021）

引用3浏览0WOS引用

T-cell Receptor Gene Therapy Targeting Melanoma-Associated Antigen-A4 by Silencing of Endogenous TCR Inhibits Tumor Growth in Mice and Human

Qian Sun,Xiying Zhang,Limei Wang,Xujie Gao,Yanjuan Xiong,Liang Liu,Feng Wei,Lili Yang,Xiubao Ren

Cell Death and Disease（2019）

引用16浏览0WOSNATURE引用

Identification of SUV39H2 As a Potential Oncogene in Lung Adenocarcinoma

Yu Zheng,Baihui Li,Jian Wang,Yanjuan Xiong,Kaiyuan Wang,Ying Qi,Houfang Sun,Lei Wu,Lili Yang

Clinical epigenetics（2018）

引用21浏览0WOS引用

Prognostic Value of Pretreatment Inflammatory Biomarkers in Advanced Lung Adenocarcinoma Patients Receiving First-Line Pemetrexed/platinum Doublet

Yanjuan Xiong,Ning Zhao,Yu Zheng,Jian Wang,Feng Wei,Xiubao Ren

Tumour biology the journal of the International Society for Oncodevelopmental Biology and Medicine（2017）

引用8浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn